Seelos Therapeutics - 22 Year Stock Price History | SEEL

Historical daily share price chart and data for Seelos Therapeutics since 1999 adjusted for splits. The latest closing stock price for Seelos Therapeutics as of September 27, 2021 is 2.39.
  • The all-time high Seelos Therapeutics stock closing price was 100175.14 on March 03, 2000.
  • The Seelos Therapeutics 52-week high stock price is 6.60, which is 176.2% above the current share price.
  • The Seelos Therapeutics 52-week low stock price is 0.72, which is 69.9% below the current share price.
  • The average Seelos Therapeutics stock price for the last 52 weeks is 2.63.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Seelos Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 3.1935 1.4600 6.3200 1.3500 2.3900 51.27%
2020 0.9476 1.3500 2.0100 0.4199 1.5800 17.91%
2019 2.3569 7.2613 8.1532 0.7201 1.3400 -76.76%
2018 19.3043 60.6607 95.7958 5.6577 5.7658 -89.57%
2017 50.7581 41.1411 96.2853 27.0270 55.2553 41.54%
2016 155.3960 291.2913 411.4114 34.2342 39.0390 -86.87%
2015 465.4239 360.3604 771.7718 255.2553 297.2973 -1.00%
2014 583.0083 777.7778 789.7898 285.2853 300.3003 -62.26%
2013 708.5407 615.6156 1024.0240 516.5165 795.7958 33.17%
2012 940.3223 1540.5405 1699.6997 570.5706 597.5976 -61.43%
2011 1372.8171 1117.1171 1777.7778 975.9760 1549.5495 48.70%
2010 1338.0814 1274.1377 3331.6675 483.4835 1042.0420 -18.79%
2009 881.8860 585.2929 2138.5704 360.1803 1283.1422 103.57%
2008 4133.5402 6798.4026 7653.8307 220.1602 630.3155 -90.14%
2007 6760.0509 3241.6224 9229.6194 3241.6224 6393.1998 111.94%
2006 3417.9780 3690.0469 5087.5463 2161.0816 3016.5098 -12.99%
2005 6113.0524 6483.2449 10085.0476 3286.6450 3466.7351 -48.67%
2004 9759.0094 17959.4887 20890.4557 5402.7041 6753.3801 -62.41%
2003 13142.1848 3826.9154 24447.2358 3732.3681 17963.9910 461.97%
2002 10704.2343 15442.7291 22691.3570 1800.9014 3196.5999 -79.12%
2001 21565.7392 35594.8152 46733.3901 9904.9574 15307.6615 -57.50%
2000 52478.5334 18571.7952 100175.1377 16599.8082 36018.0270 93.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.245B $0.000B
Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the development and advancement of novel therapeutics to address unmet medical needs for central nervous system disorders. The company's product pipeline consists of SLS-002, SLS-006, SLS-008, SLS-010 and SLS-012 which are in clinical stage. Seelos Therapeutics Inc., formerly known as Apricus Biosciences Inc., is based in New York, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29